Sign In

Crystal Icenhour

Working to change EVERYTHING about identifying infection.

Professional Background

Dr. Crystal Icenhour is a highly accomplished professional who has dedicated her career to bridging the gap between the business and scientific realms. With a strong foundation in medical science research and a passion for leadership, innovation, and commercialization, Dr. Icenhour has made significant contributions to the field of infectious disease diagnostics. She is formally trained as a medical researcher, specializing in infectious diseases, particularly fungal disease and molecular biology.

After completing her extensive training at esteemed institutions such as the Mayo Clinic and Duke University Medical Center, Dr. Icenhour co-founded her first company focusing on diagnostics for intestinal parasites and fungal infections. This early venture set the stage for her subsequent achievements and initiatives aimed at improving patient outcomes through better testing methodologies.

Notably, she served as the founding CEO of Aperiomics, an innovative precision infection testing company. Under her leadership, Aperiomics developed groundbreaking testing technologies designed to identify every known bacterium, DNA virus, parasite, and fungus in a single test. This pioneering work placed Aperiomics at the intersection of high technology and biotechnology, demonstrating Dr. Icenhour’s commitment to enhancing patient health through superior infectious disease testing solutions. Her ability to navigate the complexities of both scientific research and business strategies exemplifies her exceptional talent in the field.

Education and Achievements

Dr. Icenhour earned her Doctorate in Pathobiology & Molecular Medicine from the University of Cincinnati College of Medicine, where she honed her skills and knowledge that would later serve her well in her diverse roles in the biotechnology space. She also holds a Bachelor of Science degree in Biology from the University of Tulsa, which laid the groundwork for her career in the life sciences.

Beyond her educational credentials, Crystal's work has garnered recognition within the scientific community and the healthcare sector. Not only has she been pivotal to the development of products aimed at combating infectious diseases, but she has also demonstrated her expertise in multifaceted roles, including research, executive management, and academia.

During her tenure at Labcorp as the Microbiome & Specialty Infectious Disease Director, Dr. Icenhour advanced diagnostic testing services and strategies that have benefited countless patients. Her previous positions include Principal at Icenhour Biotech, where she provided strategic direction and oversight to emerging biotech startups, as well as serving as an Adjunct Assistant Professor of Medicine at Duke University School of Medicine, where she contributed to the education and mentorship of future scientists and medical professionals.

Crystal's previous roles such as CEO at Aperiomics and Chief Science Officer at Phthisis Diagnostics, Inc. further highlight her leadership capabilities and commitment to scientific advancement. Her experience as a Senior Postdoctoral Fellow and Research Fellow at Mayo Clinic and Duke University Health System reflects her deep-rooted knowledge and hands-on expertise in research and development.

Achievements

Dr. Icenhour's achievements are extensive and reflect her dedication to improving healthcare through innovation in infectious disease diagnostics. Notably, she has led and participated in multiple initiatives focused on technological transfer and product development, creating pathways to bring scientific research to market effectively. Crystal is recognized not only for her contributions to molecular diagnostics but also for her fundraising acumen, demonstrating her ability to secure vital financial support for scientific endeavors.

Her specialties span a wide range of critical areas, including infectious disease/pathogens, molecular diagnostics, genomics, and assay development. With particular proficiency in next-generation sequencing and nucleic acid extraction (DNA and RNA), Dr. Icenhour has been instrumental in advancing methodologies that elevate the standards of infectious disease testing. Additionally, her talents in grant writing and management showcase her ability to spearhead projects that require substantial funding and strategic oversight.

Throughout her career, Dr. Crystal Icenhour has exemplified a powerful combination of scientific expertise, business acumen, and leadership excellence. Her work continues to resonate within the biotechnology industry, where her innovative spirit and commitment to improving patient health are paving the way for new diagnostic technologies that hold the potential to change lives. As a prominent figure in the growing field of precision medicine and infectious disease diagnostics, Dr. Icenhour remains a source of inspiration for aspiring scientists and entrepreneurs alike.

Related Questions

How did Crystal Icenhour leverage her experience at renowned institutions like Mayo Clinic and Duke University to impact the biotechnology field?
What inspired Crystal Icenhour to focus on pioneering diagnostics for infectious diseases, particularly fungal infections?
In what ways has Crystal Icenhour's leadership at Aperiomics influenced the development of precision infection testing?
What are some of the key innovations introduced by Crystal Icenhour in the realm of molecular diagnostics?
How does Crystal Icenhour's background in research inform her approach to business development in biotech?
Crystal Icenhour
Add to my network

Location

Ashburn, Virginia, United States